Table 1. Clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease (sCJD). This table outlines the World Health Organization (1998), University of California San Francisco (2007), and MRI-CJD Consortium (2008) criteria for diagnosing probable sCJD and possible sCJD. Brain biopsy is required for premortem diagnosis of definite sCJD.
| World Health Organization diagnostic criteria (1998) Probable sCJD = A + at least 2 of B + at least 1 of C Possible sCJD = A + at least 2 of B + duration <2 years | |
| A. | Progressive dementia |
| B. | Specific neurological manifestations
|
| C | Laboratory tests
|
| D. | Routine investigations should not suggest an alternative diagnosis |
| University of California San Francisco diagnostic criteria (2007) Probable sCJD = A + at least 2 of B + at least 1 of C + D Possible sCJD is not defined in this criteria set | |
| A. | Rapid cognitive decline |
| B. | Specific neurological manifestations
|
| C. | Laboratory tests
|
| D. | Routine investigations do not suggest an alternative diagnosis |
| MRI-CJD Consortium diagnostic criteria (2009) Probable sCJD = at least 2 of A + at least 1 of B Possible sCJD = at least 2 of A + duration < 2 years | |
| A. | Clinical signs
|
| B. | Laboratory tests
|
sCJD, sporadic Creutzfeldt-Jakob disease; EEG, electroencephalography; CSF, Cerebrospinal fluid; MRI, magnetic resonance imaging; DWI, diffusion-weighted imaging; ADC, apparent diffusion coefficient.